HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HUTCHMED

21.880

+0.3601.67%

Volume:4.89M

Turnover:106.51M

Market Cap:19.08B

PE:5.38

High:22.140

Open:21.520

Low:21.420

Close:21.520

52wk High:30.750

52wk Low:18.360

Shares:872.00M

HK Float Shares:872.00M

Volume Ratio:1.09

T/O Rate:0.56%

Dividend:- -

Dividend Rate:- -

EPS(LYR):4.070

ROE:45.25%

ROA:-1.62%

PB:1.97

PE(LYR):5.38

PS:4.44

Loading ...

Overview Company News Filings

HK Movers | Innovative Drug Stocks Jump With TYK Medicines up 14%

Tiger Newspress

HUTCHMED's Sovleplenib Meets Main Goal of Phase 3 Study

MT Newswires Live

HUTCHMED (00013) Announces Positive Top-Line Results from Phase III Stage of ESLIM-02 Study of Sovleplenib in Warm Antibody Autoimmune Hemolytic Anemia in China

BRIEF-Hutchmed Announces Positive Topline Phase III Trial Of Sovleplenib For Warm Antibody Autoimmune Hemolytic Anemia

HUTCHMED Announces Positive Topline Results of Phase Iii Part of Eslim-02 Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China

THOMSON REUTERS

HUTCHMED (China) Ltd - Phase Iii Trial of Sovleplenib Meets Primary Endpoint

THOMSON REUTERS

BofA Adjusts Price Target on HUTCHMED (China) to $22 From $25, Maintains Buy Rating

MT Newswires Live

HUTCHMED (00013) Initiates Phase III Stage of Ongoing Study of Surufatinib Combined with Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma

HUTCHMED Launches Phase III Trial of Surufatinib and Camrelizumab Combo for Metastatic Pancreatic Cancer

HUTCHMED Initiates Phase Iii Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-NaÏVe Pancreatic Ductal Adenocarcinoma

THOMSON REUTERS

Hong Kong Stock Announcement Highlights | Everest MED: Original Product Nefecon® Technology Protected by Valid Chinese Patent ZL200980127272.5

HUTCHMED (00013) Announces NDA Acceptance and Priority Review Status in China for Savolitinib in MET-Amplified Gastric Cancer

HUTCHMED (China) Ltd - Nda for Savolitinib Accepted With Priority Review in China

THOMSON REUTERS

China NMPA Grants Priority Review to HUTCHMED's Savolitinib NDA for MET-Amplified Gastric Cancer

HUTCHMED Announces Nda Acceptance in China With Priority Review Status for Savolitinib for the Treatment of Gastric Cancer Patients With Met Amplification

THOMSON REUTERS

Hutchmed's Application for Bile Duct Cancer Accepted, Granted Priority Review in China

MT Newswires Live

BRIEF-Hutchmed (China) Says NDA For Fanregratinib Accepted With Priority Review In China

HUTCHMED (00013): NDA for Fanregratinib (HMPL-453) as Second-Line Treatment for Intrahepatic Cholangiocarcinoma Accepted in China with Priority Review

HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Fanregratinib in Second-Line Intrahepatic Cholangiocarcinoma

HUTCHMED (00013) Initiates Global Clinical Development of ATTC Candidate HMPL-A251 for Solid Tumors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/00013/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"00013","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"00013\",,,,,undefined,":{"symbol":"00013","market":"HK","secType":"STK","nameCN":"HUTCHMED","latestPrice":21.88,"timestamp":1774598900002,"preClose":21.52,"halted":0,"volume":4892000,"delay":0,"changeRate":0.01672862453531596,"floatShares":872000000,"shares":872000000,"eps":4.069550313825541,"marketStatus":"Market Closed","change":0.36,"latestTime":"03-27 16:08:20","open":21.52,"high":22.14,"low":21.42,"amount":106512850,"amplitude":0.033457,"askPrice":21.88,"askSize":26000,"bidPrice":21.86,"bidSize":22000,"shortable":3,"etf":0,"ttmEps":4.069550313825541,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774834200000},"marketStatusCode":7,"adr":0,"listingDate":1624982400000,"exchange":"SEHK","adjPreClose":21.52,"openAndCloseTimeList":[[1774575000000,1774584000000],[1774587600000,1774598400000]],"volumeRatio":1.0946755625362314,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"00013\",,,,,undefined,":{"symbol":"00013","floatShares":872000000,"roa":"-1.62%","roe":"45.25%","lyrEps":4.06955,"volumeRatio":1.0946755625362314,"shares":872000000,"dividePrice":0,"high":22.14,"amplitude":0.033457,"preClose":21.52,"low":21.42,"week52Low":18.36,"pbRate":"1.97","psRate":"4.44","week52High":30.75,"institutionHeld":0,"latestPrice":21.88,"committee":-0.083333,"eps":4.069550313825541,"divideRate":0,"volume":4892000,"delay":0,"ttmEps":4.069550313825541,"open":21.52,"prevYearClose":20.62,"prevWeekClose":21.98,"prevMonthClose":22.7,"prevQuarterClose":20.62,"fiveDayClose":21.98,"twentyDayClose":22.7,"sixtyDayClose":20.54},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/00013\",params:#limit:5,,,undefined,":[{"date":"2026-03-05","symbol":"00013","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772674200000,"name":null,"time":"","dateTimestamp":1772640000000,"actualEps":null},{"market":"HK","date":"2025-08-07","symbol":"00013","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1754496000000,"reportTimeType":"","actualEps":null},{"market":"HK","date":"2025-03-19","symbol":"00013","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742313600000,"reportTimeType":"post","actualEps":null},{"date":"2024-07-31","symbol":"00013","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722389400000,"name":null,"time":"Post Market","dateTimestamp":1722355200000,"actualEps":null},{"date":"2024-02-28","symbol":"00013","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709083800000,"name":null,"time":"","dateTimestamp":1709049600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"00013\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"00013\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3684,"buy":0.5263,"hold":0.0526,"sell":0.0526,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5263,"analysts":19,"updateTime":1773072000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/00013\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"00013","date":"2026-03-26","current":5.371508,"percent":0.729488,"low":-115.327022,"twenty":-64.679475,"median":-11.146418,"eighty":5.613566,"high":86.489551,"avg":-19.916296,"sd":44.386179,"marketCap":18220747265.18},"quantilePoints":[{"date":"2021-04-01","current":-32.26063,"twenty":-45.236445,"median":-41.474553,"eighty":-32.902271,"marketCap":31542771226.27},{"date":"2021-04-09","current":-33.137949,"twenty":-45.21463,"median":-40.874511,"eighty":-32.866224,"marketCap":32408776001.33},{"date":"2021-04-16","current":-34.129797,"twenty":-45.176895,"median":-39.924045,"eighty":-32.896113,"marketCap":33342066085.87},{"date":"2021-04-23","current":-34.843079,"twenty":-45.158193,"median":-39.648909,"eighty":-32.910215,"marketCap":33996392320.16},{"date":"2021-04-30","current":-34.438006,"twenty":-44.949106,"median":-38.737994,"eighty":-32.910215,"marketCap":33629567311.94},{"date":"2021-05-07","current":-31.821317,"twenty":-44.793919,"median":-36.188138,"eighty":-32.856988,"marketCap":31073264544.25},{"date":"2021-05-14","current":-30.312709,"twenty":-44.759774,"median":-35.109797,"eighty":-32.442963,"marketCap":29599244477.97},{"date":"2021-05-21","current":-32.458918,"twenty":-44.587641,"median":-34.795304,"eighty":-32.328974,"marketCap":31688898903.52},{"date":"2021-05-28","current":-34.354172,"twenty":-44.233022,"median":-34.67679,"eighty":-32.308223,"marketCap":33523295987.97},{"date":"2021-06-04","current":-35.068157,"twenty":-44.02004,"median":-34.722902,"eighty":-32.328974,"marketCap":34200039176.59},{"date":"2021-06-11","current":-35.414599,"twenty":-43.831085,"median":-34.901165,"eighty":-32.39408,"marketCap":34554826169.67},{"date":"2021-06-18","current":-34.032624,"twenty":-43.526239,"median":-34.747528,"eighty":-32.372468,"marketCap":33217655857.6},{"date":"2021-06-25","current":-35.828259,"twenty":-43.128739,"median":-34.687533,"eighty":-32.321681,"marketCap":41915439893.14},{"date":"2021-07-02","current":-43.838432,"twenty":-43.131259,"median":-34.795304,"eighty":-32.350855,"marketCap":51323800350.72},{"date":"2021-07-09","current":-41.097094,"twenty":-43.11866,"median":-34.946623,"eighty":-32.458918,"marketCap":48120392047.72},{"date":"2021-07-16","current":-44.549309,"twenty":-43.11866,"median":-35.17764,"eighty":-32.504369,"marketCap":52161498140.45},{"date":"2021-07-23","current":-45.310589,"twenty":-43.968485,"median":-35.414599,"eighty":-32.664215,"marketCap":53066586722.65},{"date":"2021-07-30","current":-39.696122,"twenty":-43.968485,"median":-35.710349,"eighty":-32.718751,"marketCap":55052104811.77},{"date":"2021-08-06","current":-40.119386,"twenty":-43.838432,"median":-35.936715,"eighty":-32.772304,"marketCap":55685993250.74},{"date":"2021-08-13","current":-39.097534,"twenty":-43.624984,"median":-36.168385,"eighty":-32.812154,"marketCap":54295491499.18},{"date":"2021-08-20","current":-36.065012,"twenty":-43.131259,"median":-36.652871,"eighty":-32.886877,"marketCap":50128829049.46},{"date":"2021-08-27","current":-35.744125,"twenty":-43.11866,"median":-36.55385,"eighty":-32.893559,"marketCap":49673817384.05},{"date":"2021-09-03","current":-40.719987,"twenty":-42.972307,"median":-36.652871,"eighty":-32.902271,"marketCap":56467462622.34},{"date":"2021-09-10","current":-37.614485,"twenty":-42.965897,"median":-36.860519,"eighty":-32.915511,"marketCap":52205212399.58},{"date":"2021-09-17","current":-36.698865,"twenty":-42.817468,"median":-36.851163,"eighty":-32.915735,"marketCap":50954788056.29},{"date":"2021-09-24","current":-35.293788,"twenty":-42.619127,"median":-36.851163,"eighty":-32.99451,"marketCap":49026569695.65},{"date":"2021-09-30","current":-35.120905,"twenty":-42.553949,"median":-36.698865,"eighty":-33.041991,"marketCap":48786918724.09},{"date":"2021-10-08","current":-32.006355,"twenty":-42.428812,"median":-36.55385,"eighty":-32.898786,"marketCap":44454288673.24},{"date":"2021-10-15","current":-30.941818,"twenty":-42.344074,"median":-36.22121,"eighty":-32.836106,"marketCap":42945143744.04},{"date":"2021-10-22","current":-31.083316,"twenty":-42.330034,"median":-36.065012,"eighty":-32.568307,"marketCap":43112971697.72},{"date":"2021-10-29","current":-28.737101,"twenty":-42.305064,"median":-35.939257,"eighty":-32.328974,"marketCap":39889709839.27},{"date":"2021-11-05","current":-29.069569,"twenty":-42.156472,"median":-35.828259,"eighty":-32.087231,"marketCap":40376051865.9},{"date":"2021-11-12","current":-29.581373,"twenty":-41.977957,"median":-35.758877,"eighty":-32.000321,"marketCap":41129304488.44},{"date":"2021-11-19","current":-29.210209,"twenty":-41.873989,"median":-35.52649,"eighty":-31.797403,"marketCap":40609180641.02},{"date":"2021-11-26","current":-34.003345,"twenty":-41.725093,"median":-35.418736,"eighty":-31.732478,"marketCap":47319747389.9},{"date":"2021-12-03","current":-32.23822,"twenty":-41.515823,"median":-35.293788,"eighty":-31.797403,"marketCap":44836616278.36},{"date":"2021-12-10","current":-32.455639,"twenty":-41.169167,"median":-35.18636,"eighty":-31.732478,"marketCap":45164307712.51},{"date":"2021-12-17","current":-33.631509,"twenty":-41.080874,"median":-35.068157,"eighty":-31.732478,"marketCap":46818195775.34},{"date":"2021-12-24","current":-34.101039,"twenty":-41.005597,"median":-34.923894,"eighty":-31.797403,"marketCap":47456795061.09},{"date":"2021-12-31","current":-34.446938,"twenty":-40.918244,"median":-34.795304,"eighty":-31.841664,"marketCap":47928518291.92},{"date":"2022-01-07","current":-32.437839,"twenty":-34.216934,"median":-33.768287,"eighty":-32.546096,"marketCap":45137280104.46},{"date":"2022-01-14","current":-30.159284,"twenty":-34.182769,"median":-32.528053,"eighty":-31.719401,"marketCap":41896495107.79},{"date":"2022-01-21","current":-28.701706,"twenty":-33.928688,"median":-32.110119,"eighty":-30.184656,"marketCap":39875505431.45},{"date":"2022-01-28","current":-25.003785,"twenty":-33.624079,"median":-30.96176,"eighty":-28.08003,"marketCap":34769543283.8},{"date":"2022-02-04","current":-26.206511,"twenty":-33.52794,"median":-30.605361,"eighty":-26.57407,"marketCap":36424157188.83},{"date":"2022-02-11","current":-25.261882,"twenty":-32.618267,"median":-30.159284,"eighty":-26.206511,"marketCap":35152831390.55},{"date":"2022-02-18","current":-25.371388,"twenty":-32.437839,"median":-29.083035,"eighty":-25.697923,"marketCap":35312817513.19},{"date":"2022-02-25","current":-25.683001,"twenty":-32.420193,"median":-26.763849,"eighty":-25.683001,"marketCap":35785944440.17},{"date":"2022-03-04","current":-18.605078,"twenty":-32.110119,"median":-26.464292,"eighty":-25.530976,"marketCap":28297581052.3},{"date":"2022-03-11","current":-15.051903,"twenty":-32.070016,"median":-26.326525,"eighty":-25.261882,"marketCap":22932572633.44},{"date":"2022-03-18","current":-17.884701,"twenty":-31.193478,"median":-26.166616,"eighty":-21.714134,"marketCap":27233209728.79},{"date":"2022-03-25","current":-16.435173,"twenty":-30.730042,"median":-25.903371,"eighty":-17.884701,"marketCap":25043178568.8},{"date":"2022-04-01","current":-17.213787,"twenty":-30.48068,"median":-25.690905,"eighty":-17.432216,"marketCap":26250069985.91},{"date":"2022-04-08","current":-16.063966,"twenty":-30.257393,"median":-25.643815,"eighty":-17.055219,"marketCap":24511508861.84},{"date":"2022-04-14","current":-15.298862,"twenty":-30.176199,"median":-25.515985,"eighty":-16.890995,"marketCap":23354155045.87},{"date":"2022-04-22","current":-14.712002,"twenty":-30.080898,"median":-25.416472,"eighty":-16.438181,"marketCap":22468433581.99},{"date":"2022-04-29","current":-13.558507,"twenty":-29.763736,"median":-25.004766,"eighty":-15.67506,"marketCap":20708827698.25},{"date":"2022-05-06","current":-9.781934,"twenty":-29.311832,"median":-24.536918,"eighty":-15.316521,"marketCap":14946095060.81},{"date":"2022-05-13","current":-9.355898,"twenty":-28.701706,"median":-18.605078,"eighty":-15.051903,"marketCap":14295669518.62},{"date":"2022-05-20","current":-8.719868,"twenty":-27.147517,"median":-18.156841,"eighty":-13.674415,"marketCap":13321483301.1},{"date":"2022-05-27","current":-8.314191,"twenty":-26.763849,"median":-17.757208,"eighty":-13.413532,"marketCap":12702840396.03},{"date":"2022-06-02","current":-8.658358,"twenty":-26.680207,"median":-17.536296,"eighty":-11.400721,"marketCap":13222054770.59},{"date":"2022-06-10","current":-9.214019,"twenty":-26.591115,"median":-17.134659,"eighty":-9.756609,"marketCap":14077985103.01},{"date":"2022-06-17","current":-9.914833,"twenty":-26.398424,"median":-17.044989,"eighty":-9.414775,"marketCap":15149735584.26},{"date":"2022-06-24","current":-11.463874,"twenty":-26.337619,"median":-16.800427,"eighty":-9.431663,"marketCap":17514907422.39},{"date":"2022-06-30","current":-10.693051,"twenty":-26.329273,"median":-16.438933,"eighty":-9.566068,"marketCap":16333469323.64},{"date":"2022-07-08","current":-13.343207,"twenty":-26.317962,"median":-16.04464,"eighty":-9.731284,"marketCap":20384557250.66},{"date":"2022-07-15","current":-11.176596,"twenty":-26.248808,"median":-15.477934,"eighty":-9.861673,"marketCap":17077603475.67},{"date":"2022-07-22","current":-11.270185,"twenty":-26.158638,"median":-15.298862,"eighty":-9.932971,"marketCap":17217623503.66},{"date":"2022-07-29","current":-11.175537,"twenty":-26.077318,"median":-15.12716,"eighty":-9.984048,"marketCap":17075877541.41},{"date":"2022-08-05","current":-8.775775,"twenty":-25.959775,"median":-14.816492,"eighty":-9.566068,"marketCap":17574625072.99},{"date":"2022-08-12","current":-9.033436,"twenty":-25.816533,"median":-13.616461,"eighty":-9.292049,"marketCap":18064375615.29},{"date":"2022-08-19","current":-8.567373,"twenty":-25.72221,"median":-13.480194,"eighty":-9.144939,"marketCap":17149292220.93},{"date":"2022-08-26","current":-8.387311,"twenty":-25.689502,"median":-13.337024,"eighty":-9.034157,"marketCap":16788221392.11},{"date":"2022-09-02","current":-8.548157,"twenty":-25.683356,"median":-13.200554,"eighty":-8.98009,"marketCap":17117960263.18},{"date":"2022-09-09","current":-9.050042,"twenty":-25.635977,"median":-12.78636,"eighty":-8.905022,"marketCap":18121776670.85},{"date":"2022-09-16","current":-7.943729,"twenty":-25.575167,"median":-12.324077,"eighty":-8.748156,"marketCap":15907654280.04},{"date":"2022-09-23","current":-5.590294,"twenty":-25.518983,"median":-11.743958,"eighty":-8.673581,"marketCap":11195071623.1},{"date":"2022-09-30","current":-6.0166,"twenty":-25.485219,"median":-11.587891,"eighty":-8.586381,"marketCap":12048940501.69},{"date":"2022-10-07","current":-5.591973,"twenty":-25.443523,"median":-11.527599,"eighty":-8.493517,"marketCap":11198562277.42},{"date":"2022-10-14","current":-5.380359,"twenty":-25.349487,"median":-11.463874,"eighty":-8.390524,"marketCap":10774823368.78},{"date":"2022-10-21","current":-5.717908,"twenty":-25.210459,"median":-11.223391,"eighty":-8.363292,"marketCap":11450514084.98},{"date":"2022-10-28","current":-5.527847,"twenty":-25.00457,"median":-11.166052,"eighty":-8.300859,"marketCap":11069565111.71},{"date":"2022-11-04","current":-5.851883,"twenty":-24.910412,"median":-11.069492,"eighty":-8.060636,"marketCap":11719091896.58},{"date":"2022-11-11","current":-6.401199,"twenty":-23.972361,"median":-10.858934,"eighty":-8.011233,"marketCap":12796562986.74},{"date":"2022-11-18","current":-7.274108,"twenty":-21.092323,"median":-10.673386,"eighty":-7.934524,"marketCap":14517459126.03},{"date":"2022-11-25","current":-7.207228,"twenty":-18.572304,"median":-10.157769,"eighty":-7.463009,"marketCap":14371885026.64},{"date":"2022-12-02","current":-9.190517,"twenty":-18.408401,"median":-9.929948,"eighty":-7.665665,"marketCap":18250194105.54},{"date":"2022-12-09","current":-9.61663,"twenty":-18.229044,"median":-9.65531,"eighty":-7.784213,"marketCap":19100477041.28},{"date":"2022-12-16","current":-9.580976,"twenty":-18.006141,"median":-9.63597,"eighty":-7.910568,"marketCap":19026485178.56},{"date":"2022-12-23","current":-9.787361,"twenty":-17.859202,"median":-9.65531,"eighty":-7.934524,"marketCap":19486173353.19},{"date":"2022-12-30","current":-10.536978,"twenty":-17.782707,"median":-9.784648,"eighty":-7.941428,"marketCap":20959995729.67},{"date":"2023-01-06","current":-11.292055,"twenty":-17.736585,"median":-9.867971,"eighty":-7.950701,"marketCap":22494681234.05},{"date":"2023-01-13","current":-12.006871,"twenty":-17.610912,"median":-10.008346,"eighty":-7.963783,"marketCap":23922940068.79},{"date":"2023-01-20","current":-11.709152,"twenty":-17.473848,"median":-10.118738,"eighty":-7.994464,"marketCap":23379819079.96},{"date":"2023-01-27","current":-13.678274,"twenty":-17.432216,"median":-10.177881,"eighty":-8.01117,"marketCap":27320803442.63},{"date":"2023-02-03","current":-13.421402,"twenty":-17.213787,"median":-10.426285,"eighty":-8.011486,"marketCap":26863129451.21},{"date":"2023-02-10","current":-11.253893,"twenty":-17.05553,"median":-10.648788,"eighty":-8.019975,"marketCap":22537144573},{"date":"2023-02-17","current":-11.126783,"twenty":-17.053975,"median":-10.857338,"eighty":-8.035671,"marketCap":22268002032.65},{"date":"2023-02-24","current":-10.526624,"twenty":-17.044989,"median":-10.726474,"eighty":-8.057762,"marketCap":21077513939.38},{"date":"2023-03-03","current":-8.154844,"twenty":-16.916563,"median":-10.643856,"eighty":-8.057762,"marketCap":23097865737.18},{"date":"2023-03-10","current":-6.963075,"twenty":-7.3495,"median":-7.032846,"eighty":-6.75848,"marketCap":19723143000.14},{"date":"2023-03-17","current":-6.865923,"twenty":-61.970531,"median":-35.629537,"eighty":-17.473848,"marketCap":19447482927.55},{"date":"2023-03-24","current":-6.741371,"twenty":-61.810647,"median":-35.43635,"eighty":-16.967933,"marketCap":19094937026.98},{"date":"2023-03-31","current":-6.375327,"twenty":-61.252739,"median":-35.347363,"eighty":-16.28669,"marketCap":18058416376.4},{"date":"2023-04-06","current":-6.683867,"twenty":-61.051241,"median":-35.293788,"eighty":-15.784823,"marketCap":18932274586.01},{"date":"2023-04-14","current":-8.330975,"twenty":-60.256652,"median":-35.239073,"eighty":-15.273506,"marketCap":23597702760.41},{"date":"2023-04-21","current":-7.844979,"twenty":-58.817812,"median":-35.05056,"eighty":-14.753798,"marketCap":22220992691.66},{"date":"2023-04-28","current":-7.371003,"twenty":-58.196617,"median":-34.901165,"eighty":-13.506657,"marketCap":20878585601.39},{"date":"2023-05-05","current":-7.738249,"twenty":-57.924962,"median":-34.698276,"eighty":-13.335787,"marketCap":21913541487.16},{"date":"2023-05-12","current":-6.663943,"twenty":-56.833588,"median":-34.455845,"eighty":-12.953628,"marketCap":18842198331.81},{"date":"2023-05-19","current":-5.998961,"twenty":-55.969951,"median":-34.41247,"eighty":-12.439757,"marketCap":16945371089.92},{"date":"2023-05-25","current":-5.942503,"twenty":-55.282066,"median":-34.29379,"eighty":-12.225939,"marketCap":16798971651.82},{"date":"2023-06-02","current":-5.896649,"twenty":-54.016998,"median":-34.217465,"eighty":-11.933092,"marketCap":16663068843.98},{"date":"2023-06-09","current":-5.61732,"twenty":-51.214539,"median":-34.101039,"eighty":-11.666701,"marketCap":15883210799.3},{"date":"2023-06-16","current":-6.556151,"twenty":-49.105276,"median":-34.003345,"eighty":-11.555566,"marketCap":18505315840.32},{"date":"2023-06-23","current":-5.188019,"twenty":-48.556583,"median":-33.893107,"eighty":-11.468392,"marketCap":14659329250.62},{"date":"2023-06-30","current":-5.593173,"twenty":-48.07849,"median":-33.659861,"eighty":-11.27436,"marketCap":15818891198.39},{"date":"2023-07-07","current":-5.74663,"twenty":-47.632394,"median":-33.542687,"eighty":-11.176172,"marketCap":16220083293.9},{"date":"2023-07-14","current":-6.162744,"twenty":-47.405428,"median":-33.247944,"eighty":-11.098403,"marketCap":17394445526.77},{"date":"2023-07-21","current":-6.029127,"twenty":-47.160973,"median":-33.142575,"eighty":-10.97509,"marketCap":16998620863},{"date":"2023-07-28","current":-6.932729,"twenty":-46.570339,"median":-32.990093,"eighty":-10.818361,"marketCap":19517985603.8},{"date":"2023-08-04","current":-93.761454,"twenty":-46.5265,"median":-32.963473,"eighty":-10.733158,"marketCap":21537453624.06},{"date":"2023-08-11","current":-81.599272,"twenty":-46.5265,"median":-32.963473,"eighty":-10.733158,"marketCap":18771592602.56},{"date":"2023-08-18","current":-77.394943,"twenty":-46.5265,"median":-32.963473,"eighty":-10.733158,"marketCap":17836124479.76},{"date":"2023-08-25","current":-81.144511,"twenty":-46.5265,"median":-32.963473,"eighty":-10.733158,"marketCap":18729505678.13},{"date":"2023-09-01","current":-88.78076,"twenty":-46.5265,"median":-32.963473,"eighty":-10.733158,"marketCap":20494743445.14},{"date":"2023-09-08","current":-82.097217,"twenty":-46.5265,"median":-32.963473,"eighty":-10.733158,"marketCap":18936651957.48},{"date":"2023-09-15","current":-90.981817,"twenty":-46.5265,"median":-32.963473,"eighty":-10.733158,"marketCap":20957716756.3},{"date":"2023-09-22","current":-92.393328,"twenty":-46.5265,"median":-32.963473,"eighty":-10.733158,"marketCap":21259996622.03},{"date":"2023-09-29","current":-98.461442,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":22686128273.82},{"date":"2023-10-06","current":-96.214145,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":22171083111.85},{"date":"2023-10-13","current":-103.485392,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":23822424537.65},{"date":"2023-10-20","current":-97.284175,"twenty":-46.617006,"median":-32.990093,"eighty":-10.759896,"marketCap":22394985002.25},{"date":"2023-10-27","current":-106.751795,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":24568605371.22},{"date":"2023-11-03","current":-115.212824,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":26525615085.48},{"date":"2023-11-10","current":-109.532922,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":25174318402.02},{"date":"2023-11-17","current":-106.805345,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":24505823305.05},{"date":"2023-11-24","current":-109.693138,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":25153240209.05},{"date":"2023-12-01","current":-106.604844,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":24511417094.04},{"date":"2023-12-08","current":-107.070217,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":24605471525.28},{"date":"2023-12-15","current":-113.448896,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":26053877959.74},{"date":"2023-12-22","current":-103.305924,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":23753967779.21},{"date":"2023-12-29","current":-104.554671,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":24031688424.97},{"date":"2024-01-05","current":-97.538826,"twenty":-46.632577,"median":-32.968877,"eighty":-10.746527,"marketCap":22413571331.52},{"date":"2024-01-12","current":-94.201699,"twenty":-46.770261,"median":-32.968877,"eighty":-10.746527,"marketCap":21673419911.77},{"date":"2024-01-19","current":-81.584808,"twenty":-47.074928,"median":-32.968877,"eighty":-10.746527,"marketCap":18770785863.8},{"date":"2024-01-26","current":-75.451844,"twenty":-47.074928,"median":-32.968877,"eighty":-10.746527,"marketCap":17345101973.87},{"date":"2024-02-02","current":-70.765941,"twenty":-47.074928,"median":-32.968877,"eighty":-10.746527,"marketCap":16282696381.87},{"date":"2024-02-09","current":-81.347748,"twenty":-48.716981,"median":-33.012756,"eighty":-10.798873,"marketCap":18717344761},{"date":"2024-02-16","current":-84.181649,"twenty":-47.153468,"median":-32.990093,"eighty":-10.759896,"marketCap":19373856860.76},{"date":"2024-02-23","current":-90.792994,"twenty":-47.153468,"median":-32.990093,"eighty":-10.759896,"marketCap":20902012964.26},{"date":"2024-03-01","current":25.786241,"twenty":-46.679291,"median":-32.915735,"eighty":-10.645829,"marketCap":20346139014.44},{"date":"2024-03-08","current":25.582581,"twenty":-45.940803,"median":-32.886877,"eighty":-10.481626,"marketCap":20163555295.01},{"date":"2024-03-15","current":30.565906,"twenty":-45.529936,"median":-32.817455,"eighty":-10.09532,"marketCap":24095754961.33},{"date":"2024-03-22","current":28.107757,"twenty":-45.160354,"median":-32.772304,"eighty":-9.839853,"marketCap":22154601659.66},{"date":"2024-03-28","current":28.600698,"twenty":-44.720712,"median":-32.618267,"eighty":-9.624366,"marketCap":22551295932.84},{"date":"2024-04-05","current":27.994802,"twenty":-44.347448,"median":-32.47029,"eighty":-9.452048,"marketCap":22087067767.8},{"date":"2024-04-12","current":30.73697,"twenty":-43.943873,"median":-32.437839,"eighty":-9.318497,"marketCap":24275060175.65},{"date":"2024-04-19","current":28.50518,"twenty":-43.568026,"median":-32.383262,"eighty":-9.184888,"marketCap":22496664763.16},{"date":"2024-04-26","current":30.691652,"twenty":-43.220175,"median":-32.350855,"eighty":-9.070875,"marketCap":24213782936.8},{"date":"2024-05-03","current":32.810779,"twenty":-43.064091,"median":-32.26063,"eighty":-9.029833,"marketCap":25846323266.76},{"date":"2024-05-10","current":37.311124,"twenty":-42.923343,"median":-32.110119,"eighty":-8.913389,"marketCap":29386719562.77},{"date":"2024-05-17","current":34.774349,"twenty":-42.757541,"median":-32.039099,"eighty":-8.809555,"marketCap":27344355739.56},{"date":"2024-05-24","current":31.870114,"twenty":-42.527033,"median":-31.996298,"eighty":-8.709144,"marketCap":25081686249.94},{"date":"2024-05-31","current":31.840964,"twenty":-42.416722,"median":-31.741294,"eighty":-8.632994,"marketCap":25083902865.28},{"date":"2024-06-07","current":30.649626,"twenty":-42.305053,"median":-31.616715,"eighty":-8.516477,"marketCap":24125428073.62},{"date":"2024-06-14","current":31.662211,"twenty":-42.098116,"median":-31.539189,"eighty":-8.407096,"marketCap":24922661857.41},{"date":"2024-06-21","current":30.278072,"twenty":-41.844066,"median":-31.363349,"eighty":-8.36679,"marketCap":23813100405.81},{"date":"2024-06-28","current":29.565199,"twenty":-41.728492,"median":-31.269961,"eighty":-8.329156,"marketCap":23268082119.63},{"date":"2024-07-05","current":31.469656,"twenty":-41.393066,"median":-31.203757,"eighty":-8.265452,"marketCap":24767319836.39},{"date":"2024-07-12","current":32.497273,"twenty":-41.140604,"median":-31.157735,"eighty":-8.113279,"marketCap":25570313091.93},{"date":"2024-07-19","current":32.524385,"twenty":-40.943248,"median":-31.083316,"eighty":-8.013184,"marketCap":25598824089.02},{"date":"2024-07-26","current":31.859649,"twenty":-40.85626,"median":-31.054703,"eighty":-7.947767,"marketCap":25066868429.98},{"date":"2024-08-02","current":-73.252444,"twenty":-40.85626,"median":-30.982552,"eighty":-7.932272,"marketCap":24027736404.41},{"date":"2024-08-09","current":-80.817949,"twenty":-40.943248,"median":-31.054703,"eighty":-7.932272,"marketCap":26435442267.26},{"date":"2024-08-16","current":-75.419733,"twenty":-41.140604,"median":-31.070357,"eighty":-7.932272,"marketCap":24678935821.12},{"date":"2024-08-23","current":-70.090937,"twenty":-41.393066,"median":-31.106867,"eighty":-7.932272,"marketCap":22937152798.66},{"date":"2024-08-30","current":-70.200291,"twenty":-41.753019,"median":-31.106867,"eighty":-7.932272,"marketCap":22976002955.29},{"date":"2024-09-06","current":-70.181618,"twenty":-41.891269,"median":-31.106867,"eighty":-7.932272,"marketCap":22962498278.15},{"date":"2024-09-13","current":-69.744859,"twenty":-42.126905,"median":-31.106867,"eighty":-7.932272,"marketCap":22840730551.22},{"date":"2024-09-20","current":-71.615538,"twenty":-42.327522,"median":-31.095092,"eighty":-7.932223,"marketCap":23428261601.8},{"date":"2024-09-27","current":-77.826204,"twenty":-42.433529,"median":-31.139284,"eighty":-7.932223,"marketCap":25408013958.13},{"date":"2024-10-04","current":-82.757332,"twenty":-42.534448,"median":-31.204035,"eighty":-7.932223,"marketCap":26974955119.6},{"date":"2024-10-10","current":-79.704216,"twenty":-42.711375,"median":-31.339747,"eighty":-7.932272,"marketCap":25991425637.15},{"date":"2024-10-18","current":-82.642206,"twenty":-42.92401,"median":-31.585504,"eighty":-7.932223,"marketCap":26964969038.24},{"date":"2024-10-25","current":-85.256412,"twenty":-43.079868,"median":-31.801389,"eighty":-7.932223,"marketCap":27805638314.63},{"date":"2024-11-01","current":-75.478959,"twenty":-43.248131,"median":-32.012456,"eighty":-7.932223,"marketCap":24628211107.26},{"date":"2024-11-08","current":-72.126697,"twenty":-43.829981,"median":-32.06209,"eighty":-7.932223,"marketCap":23539176621.59},{"date":"2024-11-15","current":-68.34495,"twenty":-44.05441,"median":-32.06209,"eighty":-7.932223,"marketCap":22322467758.14},{"date":"2024-11-22","current":-71.747651,"twenty":-44.586692,"median":-32.06209,"eighty":-7.932223,"marketCap":23437513999.56},{"date":"2024-11-29","current":-69.444249,"twenty":-45.156033,"median":-32.06209,"eighty":-7.932223,"marketCap":22687198483.51},{"date":"2024-12-06","current":-72.472893,"twenty":-45.310589,"median":-32.06209,"eighty":-7.932223,"marketCap":23670440899.03},{"date":"2024-12-13","current":-64.122147,"twenty":-45.873042,"median":-32.06209,"eighty":-7.932223,"marketCap":20927655990.31},{"date":"2024-12-20","current":-60.618869,"twenty":-46.617006,"median":-32.06209,"eighty":-7.932223,"marketCap":19772963718.23},{"date":"2024-12-27","current":-59.140915,"twenty":-47.153468,"median":-32.06209,"eighty":-7.932223,"marketCap":19280402620.65},{"date":"2025-01-03","current":-61.983512,"twenty":-59.140915,"median":-32.06209,"eighty":-7.932223,"marketCap":20230498655.69},{"date":"2025-01-10","current":-62.344458,"twenty":-61.433665,"median":-32.06209,"eighty":-7.932223,"marketCap":20362016758.64},{"date":"2025-01-17","current":-58.299182,"twenty":-61.674651,"median":-32.06209,"eighty":-7.932223,"marketCap":19056175109.75},{"date":"2025-01-24","current":-55.029289,"twenty":-61.674651,"median":-32.06209,"eighty":-7.932223,"marketCap":17990698549.08},{"date":"2025-01-28","current":-55.208549,"twenty":-61.626454,"median":-32.070016,"eighty":-7.932272,"marketCap":18051528064.93},{"date":"2025-02-07","current":-53.467713,"twenty":-61.736423,"median":-32.054164,"eighty":-7.928331,"marketCap":17473800278.65},{"date":"2025-02-14","current":-55.098914,"twenty":-61.736423,"median":-32.054164,"eighty":-7.928331,"marketCap":18014663367.55},{"date":"2025-02-21","current":-65.870772,"twenty":-62.054363,"median":-32.054164,"eighty":-7.928331,"marketCap":21496146081.23},{"date":"2025-02-28","current":-68.37646,"twenty":-63.154322,"median":-32.054164,"eighty":-7.928331,"marketCap":22314794720.11},{"date":"2025-03-07","current":-68.073966,"twenty":-64.442069,"median":-32.090068,"eighty":-7.92444,"marketCap":22204161239.42},{"date":"2025-03-14","current":-64.060444,"twenty":-64.442069,"median":-32.282371,"eighty":-7.92444,"marketCap":20896010785.32},{"date":"2025-03-21","current":66.690257,"twenty":-64.57142,"median":-32.359711,"eighty":-7.893063,"marketCap":19556601497.91},{"date":"2025-03-28","current":69.598373,"twenty":-64.57142,"median":-32.359711,"eighty":-7.730879,"marketCap":20419240129.11},{"date":"2025-04-03","current":69.339758,"twenty":-64.57142,"median":-32.359711,"eighty":-7.359957,"marketCap":20359402498.56},{"date":"2025-04-11","current":62.287088,"twenty":-64.57142,"median":-32.359711,"eighty":-7.206069,"marketCap":18236887121.65},{"date":"2025-04-17","current":63.677927,"twenty":-64.517393,"median":-32.350855,"eighty":-7.140497,"marketCap":18650762717},{"date":"2025-04-25","current":68.867703,"twenty":-64.625448,"median":-32.368566,"eighty":-7.03606,"marketCap":20159738053.44},{"date":"2025-05-02","current":70.00808,"twenty":-64.57142,"median":-32.359711,"eighty":-6.966686,"marketCap":20488094665.71},{"date":"2025-05-09","current":68.704213,"twenty":-64.625448,"median":-32.368566,"eighty":-6.932792,"marketCap":20149647112.01},{"date":"2025-05-16","current":61.687385,"twenty":-64.625448,"median":-32.368566,"eighty":-6.786538,"marketCap":18167966631.68},{"date":"2025-05-23","current":63.281782,"twenty":-64.625448,"median":-32.368566,"eighty":-6.729467,"marketCap":18687586410.77},{"date":"2025-05-30","current":63.269782,"twenty":-64.625448,"median":-32.368566,"eighty":-6.664543,"marketCap":18714358918.44},{"date":"2025-06-06","current":69.305193,"twenty":-64.625448,"median":-32.368566,"eighty":-6.561537,"marketCap":20515529753.86},{"date":"2025-06-13","current":77.57647,"twenty":-64.625448,"median":-32.368566,"eighty":-6.458593,"marketCap":22974331108.91},{"date":"2025-06-20","current":66.613989,"twenty":-64.625448,"median":-32.368566,"eighty":-6.38184,"marketCap":19728914894.06},{"date":"2025-06-27","current":68.13786,"twenty":-64.57142,"median":-32.359711,"eighty":-6.322569,"marketCap":20180159014.54},{"date":"2025-07-04","current":70.900488,"twenty":-64.57142,"median":-32.249425,"eighty":-6.168488,"marketCap":20998758486.41},{"date":"2025-07-11","current":72.572229,"twenty":-64.57142,"median":-32.06209,"eighty":-6.069288,"marketCap":21493799797.37},{"date":"2025-07-18","current":78.450021,"twenty":-64.57142,"median":-31.963197,"eighty":-6.016964,"marketCap":23230015089.48},{"date":"2025-07-25","current":79.176352,"twenty":-64.57142,"median":-31.658165,"eighty":-5.983916,"marketCap":23449720582.14},{"date":"2025-08-01","current":79.150274,"twenty":-64.57142,"median":-31.198617,"eighty":-5.934922,"marketCap":23442056772.78},{"date":"2025-08-08","current":5.542888,"twenty":-64.57142,"median":-31.111258,"eighty":-5.85528,"marketCap":20314350376.27},{"date":"2025-08-15","current":6.05636,"twenty":-64.57142,"median":-31.05598,"eighty":-5.831667,"marketCap":22151207664.62},{"date":"2025-08-22","current":5.906994,"twenty":-64.57142,"median":-30.692254,"eighty":-5.779673,"marketCap":21548250500.17},{"date":"2025-08-29","current":5.520039,"twenty":-64.57142,"median":-30.321403,"eighty":-5.759212,"marketCap":20090230846.52},{"date":"2025-09-05","current":5.773462,"twenty":-64.57142,"median":-29.989965,"eighty":-5.703747,"marketCap":21027659298.83},{"date":"2025-09-12","current":6.495449,"twenty":-64.57142,"median":-29.726771,"eighty":-5.622645,"marketCap":23621500664.08},{"date":"2025-09-19","current":6.361988,"twenty":-64.57142,"median":-29.414305,"eighty":-5.592693,"marketCap":23101220111.83},{"date":"2025-09-26","current":5.650636,"twenty":-64.57142,"median":-29.083297,"eighty":-5.507128,"marketCap":20526255977.63},{"date":"2025-10-03","current":5.974641,"twenty":-64.517393,"median":-28.957054,"eighty":-5.349809,"marketCap":21709889760.88},{"date":"2025-10-10","current":5.77709,"twenty":-64.57142,"median":-28.214975,"eighty":-5.27371,"marketCap":20985608740.88},{"date":"2025-10-17","current":5.438003,"twenty":-64.57142,"median":-26.616683,"eighty":5.337961,"marketCap":19730443712.06},{"date":"2025-10-24","current":5.566179,"twenty":-64.57142,"median":-26.259383,"eighty":5.491792,"marketCap":20195189553.77},{"date":"2025-10-31","current":5.323193,"twenty":-64.57142,"median":-25.831006,"eighty":5.491792,"marketCap":19308990426.21},{"date":"2025-11-07","current":5.692673,"twenty":-64.57142,"median":-25.567802,"eighty":5.549876,"marketCap":20664473360.45},{"date":"2025-11-14","current":5.538607,"twenty":-64.57142,"median":-25.210285,"eighty":5.584364,"marketCap":20092798400.87},{"date":"2025-11-21","current":5.228746,"twenty":-64.57142,"median":-20.159606,"eighty":5.584364,"marketCap":18999940774.47},{"date":"2025-11-28","current":5.415727,"twenty":-64.57142,"median":-17.820954,"eighty":5.584364,"marketCap":19670582704.56},{"date":"2025-12-05","current":5.234536,"twenty":-64.57142,"median":-17.134659,"eighty":5.584364,"marketCap":19019076300.78},{"date":"2025-12-12","current":5.038573,"twenty":-64.57142,"median":-16.800427,"eighty":5.584364,"marketCap":18305912482.21},{"date":"2025-12-19","current":4.906191,"twenty":-64.57142,"median":-15.942173,"eighty":5.584364,"marketCap":17822909245.64},{"date":"2025-12-24","current":4.883145,"twenty":-64.57142,"median":-15.388866,"eighty":5.584364,"marketCap":17727974030.88},{"date":"2026-01-02","current":5.059143,"twenty":-64.625448,"median":-15.051903,"eighty":5.587587,"marketCap":18383739842.57},{"date":"2026-01-09","current":5.365899,"twenty":-64.625448,"median":-13.674415,"eighty":5.587587,"marketCap":19520419385.62},{"date":"2026-01-16","current":5.891548,"twenty":-64.625448,"median":-13.413532,"eighty":5.599502,"marketCap":21448118633.89},{"date":"2026-01-23","current":5.589246,"twenty":-64.625448,"median":-13.200554,"eighty":5.610823,"marketCap":20347327588.79},{"date":"2026-01-30","current":5.579629,"twenty":-64.625448,"median":-12.674566,"eighty":5.613046,"marketCap":20333185945.47},{"date":"2026-02-06","current":5.333987,"twenty":-64.625448,"median":-12.234234,"eighty":5.613046,"marketCap":19458715968.33},{"date":"2026-02-13","current":5.391763,"twenty":-64.57142,"median":-11.983581,"eighty":5.612525,"marketCap":19677815314.81},{"date":"2026-02-20","current":5.446666,"twenty":-64.679475,"median":-11.771729,"eighty":5.613566,"marketCap":19871710359.24},{"date":"2026-02-27","current":5.347907,"twenty":-64.679475,"median":-11.587891,"eighty":5.613566,"marketCap":19532940378.98},{"date":"2026-03-06","current":5.35443,"twenty":-64.679475,"median":-11.511707,"eighty":5.613566,"marketCap":19122920083.78},{"date":"2026-03-13","current":5.276227,"twenty":-64.679475,"median":-11.319534,"eighty":5.613566,"marketCap":18869152677.83},{"date":"2026-03-20","current":5.082388,"twenty":-64.679475,"median":-11.232741,"eighty":5.613566,"marketCap":18189354416.86},{"date":"2026-03-26","current":5.095726,"twenty":-64.679475,"median":-11.146418,"eighty":5.613566,"marketCap":18220747265.18}],"updateTime":1774645130173},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"00013\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1155519341","title":"HK Movers | Innovative Drug Stocks Jump With TYK Medicines up 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155519341","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155519341?lang=en_us&edition=fundamental","pubTime":"2026-01-07 09:57","pubTimestamp":1767751062,"startTime":"0","endTime":"0","summary":"Innovative drug stocks jumped in Hong Kong. TYK Medicines rose 14%; Lepu Biopharma rose 5%; Akeso and Hengrui Pharm rose 4%; HUTCHMED rose 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8cf272575aa59c1c9fc76dc7d5dd9c50","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276","02410","00013","02157","09926"],"gpt_icon":0},{"id":"2601477698","title":"HUTCHMED's Sovleplenib Meets Main Goal of Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2601477698","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601477698?lang=en_us&edition=fundamental","pubTime":"2026-01-07 09:54","pubTimestamp":1767750894,"startTime":"0","endTime":"0","summary":"HUTCHMED   said a phase 3 clinical trial of sovleplenib to treat an autoimmune disorder met its primary goal, according to a Hong Kong bourse filing Wednesday.The drug was found to induce durable hemoglobin response rate between five to 24 weeks of treatment in adult patients with warm antibody autoimmune hemolytic anemia in China, the firm said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1588","BK1191","00013","BK1587"],"gpt_icon":0},{"id":"1176779538","title":"HUTCHMED (00013) Announces Positive Top-Line Results from Phase III Stage of ESLIM-02 Study of Sovleplenib in Warm Antibody Autoimmune Hemolytic Anemia in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1176779538","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176779538?lang=en_us&edition=fundamental","pubTime":"2026-01-07 08:08","pubTimestamp":1767744509,"startTime":"0","endTime":"0","summary":"The Phase III registration stage of the ESLIM-02 study evaluating the novel spleen tyrosine kinase (Syk) inhibitor sovleplenib in adult patients with warm antibody autoimmune hemolytic anemia (wAIHA)...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCM","BK1191","BK4588","III","BK1588","00013","BK4007","BK4134","BK4531","BK4585","BK1587"],"gpt_icon":0},{"id":"2601887841","title":"BRIEF-Hutchmed Announces Positive Topline Phase III Trial Of Sovleplenib For Warm Antibody Autoimmune Hemolytic Anemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2601887841","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601887841?lang=en_us&edition=fundamental","pubTime":"2026-01-07 08:02","pubTimestamp":1767744166,"startTime":"0","endTime":"0","summary":"BRIEF-Hutchmed Announces Positive Topline Phase III Trial Of Sovleplenib For Warm Antibody Autoimmune Hemolytic Anemia Jan 6 (Reuters) - HUTCHMED (China) Ltd 0013.HK:HUTCHMED ANNOUNCES POSITIVE TOPLIN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUA9876YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","00013","BK1191","BK1588"],"gpt_icon":0},{"id":"2601492798","title":"HUTCHMED Announces Positive Topline Results of Phase Iii Part of Eslim-02 Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2601492798","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601492798?lang=en_us&edition=fundamental","pubTime":"2026-01-07 08:00","pubTimestamp":1767744000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUA9876YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1588","BK1191","BK1587","00013"],"gpt_icon":0},{"id":"2601013849","title":"HUTCHMED (China) Ltd - Phase Iii Trial of Sovleplenib Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2601013849","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601013849?lang=en_us&edition=fundamental","pubTime":"2026-01-07 08:00","pubTimestamp":1767744000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUA9876YW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","BK1588","00013","BK1191"],"gpt_icon":0},{"id":"2601981678","title":"BofA Adjusts Price Target on HUTCHMED (China) to $22 From $25, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2601981678","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601981678?lang=en_us&edition=fundamental","pubTime":"2026-01-06 23:39","pubTimestamp":1767713965,"startTime":"0","endTime":"0","summary":"HUTCHMED (China) (HCM) has an average rating of buy and mean price target of $23.46, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00013"],"gpt_icon":0},{"id":"1168150943","title":"HUTCHMED (00013) Initiates Phase III Stage of Ongoing Study of Surufatinib Combined with Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1168150943","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168150943?lang=en_us&edition=fundamental","pubTime":"2026-01-05 08:12","pubTimestamp":1767571948,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) announced today the initiation of the Phase III portion of its China-based Phase II/III study evaluating surufatinib in combination with camrelizumab, nab-paclitaxel, and gemcitabine...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4531","BK4588","HCM","BK1191","III","BK1588","00013","BK4134","BK1587","BK4585"],"gpt_icon":0},{"id":"2601020084","title":"HUTCHMED Launches Phase III Trial of Surufatinib and Camrelizumab Combo for Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2601020084","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601020084?lang=en_us&edition=fundamental","pubTime":"2026-01-05 08:00","pubTimestamp":1767571218,"startTime":"0","endTime":"0","summary":"HUTCHMED  Ltd. has announced the initiation of the Phase III stage of its ongoing Phase II/III clinical trial evaluating the combination of surufatinib, camrelizumab, nab-paclitaxel, and gemcitabine as a first-line treatment for patients with metastatic pancreatic ductal adenocarcinoma in China. The first patient was dosed on December 30, 2025. Results from the Phase II portion of the trial were presented at the 2025 European Society for Medical Oncology  Asia Congress. The Phase II data showed that the combination regimen demonstrated a median progression-free survival of 7.20 months compared to 5.52 months for nab-paclitaxel plus gemcitabine alone, with a manageable safety profile. The Phase III part plans to enroll approximately 400 additional patients, with overall survival as the primary endpoint.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDLFc3tk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4588","IE00BKPKM429.USD","SG9999014013.SGD","NDAQ","LU0314104364.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014039.USD","LU2095319765.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4585","00013","BK1588","SG9999014005.SGD","BK1191","BK4112","BK1587","LU2210149790.SGD"],"gpt_icon":0},{"id":"2601020088","title":"HUTCHMED Initiates Phase Iii Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-NaÏVe Pancreatic Ductal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2601020088","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601020088?lang=en_us&edition=fundamental","pubTime":"2026-01-05 08:00","pubTimestamp":1767571203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nTUA12SXFC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1588","00013","BK1587"],"gpt_icon":0},{"id":"1196014790","title":"Hong Kong Stock Announcement Highlights | Everest MED: Original Product Nefecon® Technology Protected by Valid Chinese Patent ZL200980127272.5","url":"https://stock-news.laohu8.com/highlight/detail?id=1196014790","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196014790?lang=en_us&edition=fundamental","pubTime":"2025-12-30 23:04","pubTimestamp":1767107078,"startTime":"0","endTime":"0","summary":"Major Developments: Everest MED (01952) announced that the technology related to its original product Nefecon® is protected in China by patent ZL200980127272.5, which is currently in a valid state....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1161","02196","BK1191","01952","00013","BK1588","BK1583","00690","BK1574","BK1515","BK1587"],"gpt_icon":0},{"id":"1139978406","title":"HUTCHMED (00013) Announces NDA Acceptance and Priority Review Status in China for Savolitinib in MET-Amplified Gastric Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1139978406","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139978406?lang=en_us&edition=fundamental","pubTime":"2025-12-30 18:10","pubTimestamp":1767089426,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) announced that the New Drug Application (NDA) for savolitinib has been accepted by the China National Medical Products Administration (NMPA) and granted priority review. The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","LU1989771016.USD","LU1496350502.SGD","BK4162","BK4588","BK1587","LU1989772840.SGD","00013","BK4531","MET","LU1291159041.SGD","HCM","BK4585","BK4007","BK1191","LU1989772923.USD"],"gpt_icon":0},{"id":"2595879513","title":"HUTCHMED (China) Ltd - Nda for Savolitinib Accepted With Priority Review in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2595879513","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595879513?lang=en_us&edition=fundamental","pubTime":"2025-12-30 18:01","pubTimestamp":1767088881,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nFWN3XZ055:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1588","BK1587","00013","BK1191"],"gpt_icon":0},{"id":"2595795522","title":"China NMPA Grants Priority Review to HUTCHMED's Savolitinib NDA for MET-Amplified Gastric Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2595795522","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595795522?lang=en_us&edition=fundamental","pubTime":"2025-12-30 18:00","pubTimestamp":1767088813,"startTime":"0","endTime":"0","summary":"HUTCHMED  Ltd. announced that its New Drug Application  for savolitinib, a selective MET inhibitor, has been accepted and granted priority review by the China National Medical Products Administration  for the treatment of locally advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma patients with MET amplification who have failed at least two prior systemic treatments. This regulatory review is supported by positive Phase II study data and follows the Breakthrough Therapy Designation granted to savolitinib in 2023. If approved, savolitinib could become the first selective MET inhibitor available in China for this patient population.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HUTCHMED  Ltd. published the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDL18ssCf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2095319765.USD","BK1587","LU0314104364.USD","IE00BGHQF748.EUR","SG9999014039.USD","LU2210150020.SGD","BK1191","SG9999014013.SGD","SG9999014005.SGD","BK4585","SG9999014021.USD","LU2210149790.SGD","BK1588","00013","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK4112","NDAQ","BK4588"],"gpt_icon":0},{"id":"2595795541","title":"HUTCHMED Announces Nda Acceptance in China With Priority Review Status for Savolitinib for the Treatment of Gastric Cancer Patients With Met Amplification","url":"https://stock-news.laohu8.com/highlight/detail?id=2595795541","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595795541?lang=en_us&edition=fundamental","pubTime":"2025-12-30 18:00","pubTimestamp":1767088800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nTUA8HHJS5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00013","BK1191","BK1587","BK1588"],"gpt_icon":0},{"id":"2595781473","title":"Hutchmed's Application for Bile Duct Cancer Accepted, Granted Priority Review in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2595781473","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595781473?lang=en_us&edition=fundamental","pubTime":"2025-12-29 18:40","pubTimestamp":1767004812,"startTime":"0","endTime":"0","summary":"Hutchmed 's  new drug application for fanregratinib was accepted and granted priority review by China's National Medical Products Administration, according to a Monday Hong Kong bourse filing.The drug is for the treatment of adult patients with intrahepatic cholangiocarcinoma, or bile duct cancer, who have previously received systemic therapy.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","00013","BK1588","BK1587"],"gpt_icon":0},{"id":"2595781681","title":"BRIEF-Hutchmed (China) Says NDA For Fanregratinib Accepted With Priority Review In China","url":"https://stock-news.laohu8.com/highlight/detail?id=2595781681","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595781681?lang=en_us&edition=fundamental","pubTime":"2025-12-29 18:29","pubTimestamp":1767004182,"startTime":"0","endTime":"0","summary":"BRIEF-Hutchmed (China) Says NDA For Fanregratinib Accepted With Priority Review In ChinaDec 29 (Reuters) - HUTCHMED (China) Ltd 0013.HK:NDA FOR FANREGRATINIB ACCEPTED WITH PRIORITY REVIEW IN CHINAFurther company coverage: 0013.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nFWN3XX03R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","BK1191","00013","BK1587"],"gpt_icon":0},{"id":"1190145372","title":"HUTCHMED (00013): NDA for Fanregratinib (HMPL-453) as Second-Line Treatment for Intrahepatic Cholangiocarcinoma Accepted in China with Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1190145372","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190145372?lang=en_us&edition=fundamental","pubTime":"2025-12-29 16:41","pubTimestamp":1766997665,"startTime":"0","endTime":"0","summary":"tags.  HUTCHMED (00013): NDA for Fanregratinib (HMPL-453) as Second-Line Treatment for Intrahepatic Cholangiocarcinoma Accepted in China with Priority Review HUTCHMED (00013) announced that the New...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4531","BK1587","BK1191","BK1588","00013","HCM","BK4007","BK4585","BK4588"],"gpt_icon":0},{"id":"2595834477","title":"HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Fanregratinib in Second-Line Intrahepatic Cholangiocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2595834477","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595834477?lang=en_us&edition=fundamental","pubTime":"2025-12-29 16:35","pubTimestamp":1766997300,"startTime":"0","endTime":"0","summary":"— NDA supported by results from a Phase II registration trial in China — —Second most common form of liver cancer after hepatocellular carcinoma, with generally poorer long-term survival in comparison","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/29/3210799/0/en/HUTCHMED-Announces-NDA-Acceptance-in-China-with-Priority-Review-Status-for-Fanregratinib-in-Second-Line-Intrahepatic-Cholangiocarcinoma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","BK1587","BK1191","ORR","BK4195","PFS","BK4097","00013","BK4211","OS"],"gpt_icon":0},{"id":"1168135280","title":"HUTCHMED (00013) Initiates Global Clinical Development of ATTC Candidate HMPL-A251 for Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1168135280","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168135280?lang=en_us&edition=fundamental","pubTime":"2025-12-17 08:18","pubTimestamp":1765930716,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) announced the initiation of a global Phase I clinical development program for HMPL-A251. HMPL-A251 is a first-in-class PI3K/PIKK-HER2 antibody-targeted conjugate (ATTC), composed of...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","BK4588","BK1587","00013","BK4531","HCM","BK4585","BK4007","BK1191"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":116,"code":"91000000","status":"200"}]}}